Botulism Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Botulism Global Clinical Trials Review, H2, 2018" provides an overview of Botulism clinical trials scenario. This report provides top line data relating to the clinical trials on Botulism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Emergent BioSolutions Inc

DynPort Vaccine Company LLC

Ology Bioservices Inc

XOMA Corp

QPS Holdings LLC

Medytox Inc

ICON Plc

Emergent BioSolutions Inc

DynPort Vaccine Company LLC

Ology Bioservices Inc

XOMA Corp

QPS Holdings LLC

Medytox Inc

ICON Plc

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Botulism to Infectious Disease Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

Clinical Trials by Trial Status 17

Clinical Trials by End Point Status 18

Subjects Recruited Over a Period of Time 19

Clinical Trials by Sponsor Type 20

Prominent Sponsors 21

Top Companies Participating in Botulism Therapeutics Clinical Trials 23

Prominent Drugs 24

Clinical Trial Profile Snapshots 25

Appendix 34

Abbreviations 34

Definitions 34

Research Methodology 35

Secondary Research 35

About GlobalData 36

Contact Us 36

Source 37

List of Tables

Botulism Therapeutics, Global, Clinical Trials by Region, 2018* 7

Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Botulism Therapeutics, Global ...

Botulism Therapeutics, Global, Clinical Trials by Region, 2018* 7

Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 10

Botulism Therapeutics Clinical Trials, Europe, Top Countries, 2018* 11

Botulism Therapeutics Clinical Trials, North America, Top Countries, 2018* 12

Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 13

Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14

Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15

Botulism Therapeutics, Global, Clinical Trials by Phase, 2018* 16

Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2018* 17

Botulism Therapeutics Clinical Trials, Global, by End Point Status, 2018* 18

Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 19

Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 20

Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 21

Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23

Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24

List of Figures

Botulism Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Botulism Therapeutics, Global ...

Botulism Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 9

Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 10

Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 13

Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 14

Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 15

Botulism Therapeutics, Global, Clinical Trials by Phase (%), 2018* 16

Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2018* 17

Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 19

Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 20

Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 21

Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23

Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 24

GlobalData Methodology 35

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports